Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ribobay Pharma Integrates Cytiva’s FlexFactory Platform for Oligonucleotides | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Ribobay Pharma Integrates Cytiva’s FlexFactory Platform for Oligonucleotides

Will rapidly expand its oligo CRDMO business, producing several hundred kilograms of pharmaceutical oligo per year.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Ribobay Pharma, a Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, has tapped Cytvia’s first FlexFactory platform for oligonucleotide (oligo) manufacturing to provide cGMP-level oligo CRDMO services to the world.
 
It is scheduled to commence manufacturing in June and expects to produce several hundred kilograms of pharmaceutical oligo per year, bringing increased reliability, speed, and efficiency to the development of novel therapies.
 
Jingui Yong, General Manager of Ribobay Pharma, says: “With the support of Cytiva, we will rapidly expand our oligo CRDMO business by manufacturing high-quality and diversified innovative drugs, as well as new vaccine adjuvant (CpG-ODNs) for global customers. We look forward to building on synergies and creating more value with our collaborators.”
 
With the FlexFactory platform, Ribobay Pharma can better serve its customers, providing process development support, optimization, method development, pilot production services, and customized manufacturing services.
 
Allen Li, President of Cytiva in China, says: “It’s an honor to work with Ribobay Pharma to roll out our very first FlexFactory platform for oligos. We will continue facilitating more Chinese companies to navigate the global market, and ultimately help improve the accessibility of life-changing therapies for global patients.”
 
The collaboration between Cytiva and Ribobay Pharma is a response to market needs and developmental bottlenecks. Cytiva provides Ribobay Pharma with integrated services, from factory design to equipment and technologies that enable cGMP manufacturing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters